Literature DB >> 15828879

Clinical and electrophysiological characteristics of Brugada syndrome caused by a missense mutation in the S5-pore site of SCN5A.

Hideki Itoh1, Masami Shimizu, Hiroshi Mabuchi, Keiji Imoto.   

Abstract

Brugada syndrome is an inherited cardiac disorder caused by mutations in the SCN5A gene encoding the cardiac sodium channel alpha-subunit, and potentially leads to ventricular fibrillation and sudden death. We report a case of a novel SCN5A mutation associated with Brugada syndrome. A 51-year-old man suffered from recurrent nocturnal syncopal attacks due to polymorphic ventricular tachycardia. His electrocardiogram showed ST-segment elevation in V1-V3 leads, but there was no evidence of structural heart disease. DNA sequence analysis of SCN5A in this patient revealed a missense mutation (R282H) in the S5-pore region of domain I. This mutational change was not present in 100 healthy Japanese controls. In the patient's family, a 36-year-old brother had died suddenly. Genetic analysis identified two other carriers of the R282H mutation, who had ST-segment elevation and slightly increased QRS widths, but they experienced no syncopal episodes or ventricular fibrillation. Electrophysiological investigation of the R282H mutant channel expressed in cultured cells showed a severe reduction in sodium current density and a mild positive shift of activation curve. R282H did not enhance intermediate inactivation. Single-channel conductance of R282H was slightly decreased compared with WT. The electrophysiological characteristics of the R282H channel are suggested to be closely related to the clinical phenotype of Brugada syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15828879     DOI: 10.1046/j.1540-8167.2005.40606.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  6 in total

1.  A sodium channel pore mutation causing Brugada syndrome.

Authors:  Arnold E Pfahnl; Prakash C Viswanathan; Raul Weiss; Lijuan L Shang; Shamarendra Sanyal; Vladimir Shusterman; Cari Kornblit; Barry London; Samuel C Dudley
Journal:  Heart Rhythm       Date:  2006-09-28       Impact factor: 6.343

2.  A novel strategy using cardiac sodium channel polymorphic fragments to rescue trafficking-deficient SCN5A mutations.

Authors:  Krekwit Shinlapawittayatorn; Lynn A Dudash; Xi X Du; Lisa Heller; Steven Poelzing; Eckhard Ficker; Isabelle Deschênes
Journal:  Circ Cardiovasc Genet       Date:  2011-08-12

3.  Ventricular tachycardia in a Brugada syndrome patient caused by a novel deletion in SCN5A.

Authors:  J Tfelt-Hansen; T Jespersen; J Hofman-Bang; H Borger Rasmussen; P Cedergreen; F Skovby; H Abriel; J Hastrup Svendsen; Soren-Peter Olesen; M Christiansen; S Haunso
Journal:  Can J Cardiol       Date:  2009-03       Impact factor: 5.223

Review 4.  SCN5A gene mutations and the risk of ventricular fibrillation and syncope in Brugada syndrome patients: A meta-analysis.

Authors:  Sunu Budhi Raharjo; Rido Maulana; Irma Maghfirah; Fatimah Alzahra; Agnes Dinar Putrinarita; Dicky A Hanafy; Yoga Yuniadi
Journal:  J Arrhythm       Date:  2018-07-26

5.  A novel missense mutation, I890T, in the pore region of cardiac sodium channel causes Brugada syndrome.

Authors:  Anna Tarradas; Elisabet Selga; Pedro Beltran-Alvarez; Alexandra Pérez-Serra; Helena Riuró; Ferran Picó; Anna Iglesias; Oscar Campuzano; Víctor Castro-Urda; Ignacio Fernández-Lozano; Guillermo J Pérez; Fabiana S Scornik; Ramon Brugada
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

Review 6.  Physiological and Pathophysiological Insights of Nav1.4 and Nav1.5 Comparison.

Authors:  Gildas Loussouarn; Damien Sternberg; Sophie Nicole; Céline Marionneau; Francoise Le Bouffant; Gilles Toumaniantz; Julien Barc; Olfat A Malak; Véronique Fressart; Yann Péréon; Isabelle Baró; Flavien Charpentier
Journal:  Front Pharmacol       Date:  2016-01-14       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.